Learn More


 
MBA Tools
MBA Glossary

 


Infinity Pharmaceuticals Inc. - INFI - Financial Statement Analysis

All financial statement analysis reports for your requested company can be accessed below. The SIC # column is the SIC Code for the industry under which the current company is analyzed. When a report is purchased the SIC Code indicated is the industry that the company displayed will be compared against. If a different industry is desired for comparison, purchase of a separate industry analysis is suggested.

In addition to the ratio analysis reports, the latest business news headlines involving your company or industry sector are hyperlinked for your convenience along with the stock ticker for the company displayed.

Financial statement analysis updated: May 19, 2013

 

Infinity Pharmaceuticals Inc. - SIC # 2834

Ticker Exchange SIC # Website Latest Ticker
INFI Nasdaq 2834 http://www.infi.com 25.13 Stock Down -0.48

Select one of the five (5) financial statement analysis reports below to view the ratio analysis report for your selected company:

Latest Headlines for Infinity Pharmaceuticals Inc.

What’s Moving These Biotech Stocks? - May 19th, 2013 11:11 am
INFINITY PHARMACEUTICALS, INC. Financials - May 14th, 2013 11:04 am
Trader sees limit to Infinity downside - May 14th, 2013 9:20 am
[video] Biotech's Next Big Thing: ASCO - May 9th, 2013 7:39 am
Narrower than Expected Loss at Infinity - May 9th, 2013 6:35 am


View All Current Headlines >>

Bookmark and Share
facebooktwitter